• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

苯磺酰胺类IDO1抑制剂的设计、合成和生物活性

金双龙, 王芳, 邹毅, 王燕, 胡月, 郭文洁, 徐强, 赖宜生

金双龙, 王芳, 邹毅, 王燕, 胡月, 郭文洁, 徐强, 赖宜生. 苯磺酰胺类IDO1抑制剂的设计、合成和生物活性[J]. 中国药科大学学报, 2018, 49(1): 34-38. DOI: 10.11665/j.issn.1000-5048.20180105
引用本文: 金双龙, 王芳, 邹毅, 王燕, 胡月, 郭文洁, 徐强, 赖宜生. 苯磺酰胺类IDO1抑制剂的设计、合成和生物活性[J]. 中国药科大学学报, 2018, 49(1): 34-38. DOI: 10.11665/j.issn.1000-5048.20180105
JIN Shuanglong, WANG Fang, ZOU Yi, WANG Yan, HU Yue, GUO Wenjie, XU Qiang, LAI Yisheng. Design, synthesis and biological evaluation of phenylsulfonamide-based IDO1 inhibitors[J]. Journal of China Pharmaceutical University, 2018, 49(1): 34-38. DOI: 10.11665/j.issn.1000-5048.20180105
Citation: JIN Shuanglong, WANG Fang, ZOU Yi, WANG Yan, HU Yue, GUO Wenjie, XU Qiang, LAI Yisheng. Design, synthesis and biological evaluation of phenylsulfonamide-based IDO1 inhibitors[J]. Journal of China Pharmaceutical University, 2018, 49(1): 34-38. DOI: 10.11665/j.issn.1000-5048.20180105

苯磺酰胺类IDO1抑制剂的设计、合成和生物活性

基金项目: 国家自然科学基金资助项目(No.21472244,No.21472091,No.21772233) #金双龙和王芳对本论文的贡献相同

Design, synthesis and biological evaluation of phenylsulfonamide-based IDO1 inhibitors

  • 摘要: 在IDO1抑制剂 U - 3i 的基础上,利用生物电子等排原理,结合分子对接技术,设计并合成了11个苯磺酰胺类目标化合物。采用基于HeLa细胞的酶学测定方法评价了目标化合物对IDO1活性的影响,结果表明,大多数化合物对IDO1显示不同程度的抑制活性。其中,化合物 3b3e 的抑制作用最强,而且能够逆转IDO1介导的免疫抑制,值得进一步研究。
    Abstract: Based on the reported IDO1 inhibitor U - 3i , 11 phenylsulfonamide derivatives were designed and synthesized by adopting bioisosterism and molecular docking technology. The inhibitory activities of the target compounds against IDO1 were determined by the HeLa cell-based kynurenine assay. The results demonstrated that most compounds showed different degrees of inhibitory effects on IDO1. Among them, compounds 3b and 3e displayed the most potent activity and could reverse IDO1-mediated immune suppression, which might be worth of further investigation.
  • [1] Uyttenhove C,Pilotte L,Théate I,et al.Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase[J].Nat Med,2003,9(10):1269-1274.
    [2] Platten M,von Knebel Doeberitz N,Oezen I,et al.Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors[J].Front Immunol,2015,5:673.
    [3] Cheng MF, Hung MS, Song JS, et al. Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors[J].Bioorg Med Chem Lett,2014,24(15):3403-3406.
    [4] Nelson SD.Metabolic activation and drug toxicity[J].J Med Chem,1982,25(7):753-765.
    [5] Zou Y,Wang F,WANG Y,et al.Discovery of imidazoleisoindole derivatives as potent IDO1 inhibitors:design,synthesis,biological evaluation and computational studies[J].Eur J Med Chem,2017,140:293-304.
    [6] Jones G,Willett P,Glen RC,et al.Development and validation of a genetic algorithm for flexible docking[J].J Mol Biol,1997,267(3):727-748.
计量
  • 文章访问数:  841
  • HTML全文浏览量:  0
  • PDF下载量:  1178
  • 被引次数: 0
出版历程
  • 刊出日期:  2018-02-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭